A new randomized trial shows that GLP-1 weight-loss drugs like liraglutide help reduce weight but don't improve physical ...

A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...

Three global experts in endocrinology and diabetes on Monday shared new insights and the latest research on treatment options ...

GLP-3s are more potent than GLP-1s, and the side effects may be stronger. You can experience nausea, diarrhea, or constipation. That’s why it’s important to take them under medical supervision, ...

Eli Lilly ( LLY 2.05%) delivered a gain worthy of a technology growth stock last year. The pharma giant's shares soared 39%, ...

Bunnie XO shares her harrowing experience with an experimental weight-loss drug, describing severe depression and suicidal ...

According to a November poll from the Kaiser Family Foundation, one in eight Americans reported taking a GLP-1 drug, which ...

The State Oil Fund of the Republic of Azerbaijan has signed long-term strategic partnerships with Brookfield Asset Management ...

India, meanwhile, witnessed the launch of three global obesity blockbusters last year—Mounjaro, Wegovy, and Ozempic (approved for type-2 diabetes but widely used off-label for obesity). All three have ...

In an interview with BioPharma Dive, the veteran biotech CEO said there remains a “significant opportunity” for young companies in a market dominated by Novo Nordisk and Eli Lilly.

A ‘triple-strength’ weight-loss jab has just been approved by NHS watchdog Medicines and Healthcare products Regulatory ...

The Traitors star Stephen Libby is hoping to make it to the end of the his BBC show and bag the huge cash prize - and he is ...